{"ticker": {"uuid": "68e7fda6-e671-4517-a327-a9a7620e4811", "symbol": "BEAM", "name": "Beam Therapeutics Inc.", "exchange": "MEX", "country": "MX", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Beam Therapeutics stock soars 21% in three months: Here's why", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQRGxWV3JTRU1VN0lZaThXVHVmalZ5SjYwYWNmMVNpMUlNRXZfakVIbVpYLXRpQURzYWlMT0h3UGtOY1VpRm43eVE2aXZJc2FWdnVUMFM5R2VPUTRjVWI1REk1NnllLW9oU2xxYU5OTG0tZ1Qtd0E1aDZkaU5EYlZxc193cktiRHZlVlZtRF92UG5fVzBlOEQ3NllrYTVmZTNMTElGMkp2MUVfM3dZcFE?oc=5", "source_name": "MSN", "published_at": "2026-06-22T21:07:39+00:00", "published_display": "22 Jun 2026 21:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Beam Therapeutics president exercises 35,505 options | BEAM Insider Trading", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNcGItMFJvTGZ3d2p4RGlSdnpkY1RpcG9pNG80cm5SZ283VHp1VHRRdmk5QnZxT3Y3eTFMaXI5dGxuWjFySkRhdGpsQS1Nb2tMRFNVc0c4WjNaS2ZLdHpRX2FIZmdYUHhUcUFnRkFvSmxKTmpXTVlHUlVSTmduT2pQS0NlcElvMEpUMHNBbGVGcmhOWjdaNVpIVnlVUERLMU5qRlpoOVp4ajhHTUtieUdwYlB5dWJUZw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-22T20:05:05+00:00", "published_display": "22 Jun 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Beam Therapeutics stock hits 52-week high at 36.66 USD", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQU2dxU2VNRmlzajZ3NmItOGtjbmxEVTcyQUlleVZCbHJZdlY3b0IyVERKTG9CdkVaZ1FsemM2NE56NURQeVJCMFBYamNJWWI3TW85S1JsMkRTS3ZUMXoyMVBEQ1N2TVdtdk5vSndxUkxpd29XX19ZTko4dk4yN2dNY295LTQ1SmZzTXFxeXJhc19SSGkzRVU0YnlkcExWWkI1cTZGUFota3lncDlxa1E?oc=5", "source_name": "Investing.com", "published_at": "2026-06-22T13:55:33+00:00", "published_display": "22 Jun 2026 13:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Beam Therapeutics (BEAM) Is Up 16.1% After FDA Clears Platform-Based PKU Gene-Editing Trial", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-19T18:56:23+00:00", "published_display": "19 Jun 2026 18:56", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BEAM News | BEAM THERAPEUTICS INC (NASDAQ:BEAM)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiW0FVX3lxTE9UcXpfZTFzbjNuSnRscl80ekxhdmIycmN5dzNkZFNjeWVpRFV5dlE3VzRVNDNWOUwxN2w0cm1LYWZkQVlqNkJ4ZDZwdjNpYlBoTFo2MVM4ZU1oQ00?oc=5", "source_name": "ChartMill", "published_at": "2026-06-19T00:00:01+00:00", "published_display": "19 Jun 2026 00:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Beam Therapeutics Inc. (BEAM) One of the Best Genomics Stocks to Buy According to Analysts?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxNZHhBOUQ0N05rWkNTRDVwb21hYl9VaWJoZzR4alpITno3RlFjQlhEeUdNZXFhd2ZFcHFRakZ0eHZEWjFocWZTZGlobkhpMjg4QTJ5d3MyNGhwemNFelFBaEpMQlpmb1VlaDJsak8xSEJlZWxBSEhrYzZRWGlUSndYdFFLaWVSMlI5T2NrNDlwWTJTQlVWMFE?oc=5", "source_name": "Market source", "published_at": "2026-06-16T12:53:46+00:00", "published_display": "16 Jun 2026 12:53", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Better Gene-Editing Stock: CRISPR Therapeutics or Beam Therapeutics?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxQRkZkQXhHbGpOUHdCVnpYc1FEUjhUVEY1dkE1M041NnZ3SG51cEJkd05wOW1nazRKd1VldnNSV3o2eW95MWh6Nkdqa3htZGpoTVpYX0RZZS1xM3M2bUltVlE1Y25kcFdPR1Z5elJHU0hodjFycWJvTEg4TFJJalNuSk51QUxvaDdyc0hpWGF0S2ZhajRGYTJESA?oc=5", "source_name": "The Motley Fool", "published_at": "2026-05-25T07:00:00+00:00", "published_display": "25 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Two Programs That Could Make or Break Beam Therapeutics Inc (BEAM) Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPdkdZdUlyOFdGRWlUdlYxb2Z4NC0zRXk5R0pKUVRtc2VjTFpRMnF5V292UE9YQlYzci1EZXd0N0Y5Y0RUY1dwV1NVSEhwZG9SenRLMmZBamxtVFFVQm5QOXV0ckpEa2xwbUZxY2hCTHV1cnk5MVBEQk9DRllmaWRMZlk2VmdEbFg5d3RxbEZOQjlnd21UM3ZkektLS04xcUE?oc=5", "source_name": "Market source", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Beam Therapeutics Inc. (BEAM) Reports Q1 Loss, Beats Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxONDlsQ3NMU0RQU1hGWHVRR0F4SlpKa1hWZGNVM3VxS01YZGZGbkpNWTJ3SmhYZnRpaUNDbk4xbkhDU29LMnlUck1DX2ZhVm8ya3Z0T24zcXFQOWsxNk80REpSS0twN2N2V0ZEY2VhVWZoNGw1YU1JZGp0M2V3enhfRlFnSzNyTmVKeGhUclB3RHJyR19UNkZ0dWpPVmloZ2hjQkRnZGh3?oc=5", "source_name": "Market source", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Beam Therapeutics Inc. (BEAM) A Good Stock To Buy Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxObFEyRmcwZ0Y0MXJLaGtoV2VyQm5hb1FrVFlxN2F5V2VMOFpIVHZfNmY1X1NOSi10S1JPZUt4SkI0SGJ3OXZ1LVEteTg1YzRrbGE2eEtVb0pYQ2x0SFZlTkVoZXowNFZ5NXI2RXNXMk11QklGOHV4ZTNWZ2JBOGs4ZUktRHNyN0FVdzQ4WFIxQTZXT2FlZ05sZDhpYlE?oc=5", "source_name": "Market source", "published_at": "2026-05-02T07:00:00+00:00", "published_display": "02 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jim Cramer Believes Beam Therapeutics Is a \u201cSpeculative Situation\u201d", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNanB0aTlraUZBVkQyTlAxVFNXVDVEMFQwMy1zckItVFRWZHZzOXh6aEF5UGZVTHFaaDN6MFFmaWZ3MjUxWHpsbmJidVhYQnN5VTlEVF9Yc1hjV1Z4aUhpdmFJcW5rRk1Qb2x4SFQ1MUgzWnYxaWVIMEUwaVFPXzVhQ05UOTJEa1JWdjdqOEtHaFRlamJJUzJfTlMyMWFWMGtWYW0ySw?oc=5", "source_name": "Market source", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Beam Therapeutics Stock Surges 23% in 6 Months: What's Driving It?", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNaXhDYUh6aGt6ZTVKTmhEcVh1TnhwS0FuS0hIa29VWjJVUVFuc1o1MHRoTXh2V05YeEFiazEyZGZlWXlGM2N6MnNDOHhJMEJtN0g2ZGZ4QkcyMDFJdXZTQTN1ZTAwalBybTM1Rm1pNmt3VVhTaDlVSE9JZDVBTXBvVE1TSjNRQQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Beam Therapeutics Stock Price Forecast. Should You Buy BEAM?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiSEFVX3lxTE5iZ09lRzFDbkdrNnUyMUxGMU93OUMzeEJhMDVveFlEZ1N1QlhETjJNUTNZUTR1YXQ2aF9UTVZlT2RrQk4xVW5uLQ?oc=5", "source_name": "StockInvest.us", "published_at": "2020-12-01T20:47:15+00:00", "published_display": "01 Dec 2020 20:47", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Beam Therapeutics stock soars 21% in three months: Here's why", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQRGxWV3JTRU1VN0lZaThXVHVmalZ5SjYwYWNmMVNpMUlNRXZfakVIbVpYLXRpQURzYWlMT0h3UGtOY1VpRm43eVE2aXZJc2FWdnVUMFM5R2VPUTRjVWI1REk1NnllLW9oU2xxYU5OTG0tZ1Qtd0E1aDZkaU5EYlZxc193cktiRHZlVlZtRF92UG5fVzBlOEQ3NllrYTVmZTNMTElGMkp2MUVfM3dZcFE?oc=5", "source_name": "MSN", "published_at": "2026-06-22T21:07:39+00:00", "published_display": "22 Jun 2026 21:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Beam Therapeutics president exercises 35,505 options | BEAM Insider Trading", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNcGItMFJvTGZ3d2p4RGlSdnpkY1RpcG9pNG80cm5SZ283VHp1VHRRdmk5QnZxT3Y3eTFMaXI5dGxuWjFySkRhdGpsQS1Nb2tMRFNVc0c4WjNaS2ZLdHpRX2FIZmdYUHhUcUFnRkFvSmxKTmpXTVlHUlVSTmduT2pQS0NlcElvMEpUMHNBbGVGcmhOWjdaNVpIVnlVUERLMU5qRlpoOVp4ajhHTUtieUdwYlB5dWJUZw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-22T20:05:05+00:00", "published_display": "22 Jun 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Beam Therapeutics stock hits 52-week high at 36.66 USD", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQU2dxU2VNRmlzajZ3NmItOGtjbmxEVTcyQUlleVZCbHJZdlY3b0IyVERKTG9CdkVaZ1FsemM2NE56NURQeVJCMFBYamNJWWI3TW85S1JsMkRTS3ZUMXoyMVBEQ1N2TVdtdk5vSndxUkxpd29XX19ZTko4dk4yN2dNY295LTQ1SmZzTXFxeXJhc19SSGkzRVU0YnlkcExWWkI1cTZGUFota3lncDlxa1E?oc=5", "source_name": "Investing.com", "published_at": "2026-06-22T13:55:33+00:00", "published_display": "22 Jun 2026 13:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Beam Therapeutics (BEAM) Is Up 16.1% After FDA Clears Platform-Based PKU Gene-Editing Trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxQUWdSanMxYi1rdUZvMTk1WWVsb09jN3lBbmcyeVU2aTVGMXhneGdDM3BtMjhLUEIxamtUNVgwY0x4aGRYeUZEbGRBWU4wZnMxa2pFOTY4YXZYYU5uYlJ3emE0SkNhN19hekdMZjZnVW9BS3pMLVl4bzlobW9tQ0s0Tll2OWg2Q3Rrd0hKbDhQbkk1V19ZbllOejFCa1ZYMGpMQ2dXWVhnTzM1aXowaDc5WFZyQ1pTcUZMNVhtdWVrT3pNMXFxcm5zSDZrc3p4NkxSRXJ0bGZRUTNwNGU3UTN5U0JuOUNuZ9IB6wFBVV95cUxNYThzM1ozVlU1aWI5cWNvYl9Dc0diTTNYaDlXRTdOaEFqRzhkTGZobjZTTThSU3hlYTQxZ0hfWDc4LTlnRVdxVXN4bkhYMmc2UlYwT3pBSVpjYjBwamF4dHVIeHB3QWpibm5rOXlEZDFLZEIxZHFMVk1mRG0yd2NBaU55UWc3cWVPeFZHTkh6S2p4QWRXTEpjMzBDMlJDVEUyODFxdG9KajdKWHRRRGRRNENCUTJndmw0c1NOb2dLaHhsa3BXYWhBdzhKLVlsZVcyZ1lfeWlWSjZtUFpRaW1QY3hrdnlzZHBubVIw?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-19T18:56:23+00:00", "published_display": "19 Jun 2026 18:56", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BEAM News | BEAM THERAPEUTICS INC (NASDAQ:BEAM)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiW0FVX3lxTE9UcXpfZTFzbjNuSnRscl80ekxhdmIycmN5dzNkZFNjeWVpRFV5dlE3VzRVNDNWOUwxN2w0cm1LYWZkQVlqNkJ4ZDZwdjNpYlBoTFo2MVM4ZU1oQ00?oc=5", "source_name": "ChartMill", "published_at": "2026-06-19T00:00:01+00:00", "published_display": "19 Jun 2026 00:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Beam Therapeutics Inc. (BEAM) One of the Best Genomics Stocks to Buy According to Analysts?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxNZHhBOUQ0N05rWkNTRDVwb21hYl9VaWJoZzR4alpITno3RlFjQlhEeUdNZXFhd2ZFcHFRakZ0eHZEWjFocWZTZGlobkhpMjg4QTJ5d3MyNGhwemNFelFBaEpMQlpmb1VlaDJsak8xSEJlZWxBSEhrYzZRWGlUSndYdFFLaWVSMlI5T2NrNDlwWTJTQlVWMFE?oc=5", "source_name": "Market source", "published_at": "2026-06-16T12:53:46+00:00", "published_display": "16 Jun 2026 12:53", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Better Gene-Editing Stock: CRISPR Therapeutics or Beam Therapeutics?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxQRkZkQXhHbGpOUHdCVnpYc1FEUjhUVEY1dkE1M041NnZ3SG51cEJkd05wOW1nazRKd1VldnNSV3o2eW95MWh6Nkdqa3htZGpoTVpYX0RZZS1xM3M2bUltVlE1Y25kcFdPR1Z5elJHU0hodjFycWJvTEg4TFJJalNuSk51QUxvaDdyc0hpWGF0S2ZhajRGYTJESA?oc=5", "source_name": "The Motley Fool", "published_at": "2026-05-25T07:00:00+00:00", "published_display": "25 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Two Programs That Could Make or Break Beam Therapeutics Inc (BEAM) Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPdkdZdUlyOFdGRWlUdlYxb2Z4NC0zRXk5R0pKUVRtc2VjTFpRMnF5V292UE9YQlYzci1EZXd0N0Y5Y0RUY1dwV1NVSEhwZG9SenRLMmZBamxtVFFVQm5QOXV0ckpEa2xwbUZxY2hCTHV1cnk5MVBEQk9DRllmaWRMZlk2VmdEbFg5d3RxbEZOQjlnd21UM3ZkektLS04xcUE?oc=5", "source_name": "Market source", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Beam Therapeutics Inc. (BEAM) Reports Q1 Loss, Beats Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxONDlsQ3NMU0RQU1hGWHVRR0F4SlpKa1hWZGNVM3VxS01YZGZGbkpNWTJ3SmhYZnRpaUNDbk4xbkhDU29LMnlUck1DX2ZhVm8ya3Z0T24zcXFQOWsxNk80REpSS0twN2N2V0ZEY2VhVWZoNGw1YU1JZGp0M2V3enhfRlFnSzNyTmVKeGhUclB3RHJyR19UNkZ0dWpPVmloZ2hjQkRnZGh3?oc=5", "source_name": "Market source", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Beam Therapeutics Inc. (BEAM) A Good Stock To Buy Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxObFEyRmcwZ0Y0MXJLaGtoV2VyQm5hb1FrVFlxN2F5V2VMOFpIVHZfNmY1X1NOSi10S1JPZUt4SkI0SGJ3OXZ1LVEteTg1YzRrbGE2eEtVb0pYQ2x0SFZlTkVoZXowNFZ5NXI2RXNXMk11QklGOHV4ZTNWZ2JBOGs4ZUktRHNyN0FVdzQ4WFIxQTZXT2FlZ05sZDhpYlE?oc=5", "source_name": "Market source", "published_at": "2026-05-02T07:00:00+00:00", "published_display": "02 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jim Cramer Believes Beam Therapeutics Is a \u201cSpeculative Situation\u201d", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNanB0aTlraUZBVkQyTlAxVFNXVDVEMFQwMy1zckItVFRWZHZzOXh6aEF5UGZVTHFaaDN6MFFmaWZ3MjUxWHpsbmJidVhYQnN5VTlEVF9Yc1hjV1Z4aUhpdmFJcW5rRk1Qb2x4SFQ1MUgzWnYxaWVIMEUwaVFPXzVhQ05UOTJEa1JWdjdqOEtHaFRlamJJUzJfTlMyMWFWMGtWYW0ySw?oc=5", "source_name": "Market source", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Beam Therapeutics Stock Surges 23% in 6 Months: What's Driving It?", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNaXhDYUh6aGt6ZTVKTmhEcVh1TnhwS0FuS0hIa29VWjJVUVFuc1o1MHRoTXh2V05YeEFiazEyZGZlWXlGM2N6MnNDOHhJMEJtN0g2ZGZ4QkcyMDFJdXZTQTN1ZTAwalBybTM1Rm1pNmt3VVhTaDlVSE9JZDVBTXBvVE1TSjNRQQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Beam Therapeutics Stock Price Forecast. Should You Buy BEAM?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiSEFVX3lxTE5iZ09lRzFDbkdrNnUyMUxGMU93OUMzeEJhMDVveFlEZ1N1QlhETjJNUTNZUTR1YXQ2aF9UTVZlT2RrQk4xVW5uLQ?oc=5", "source_name": "StockInvest.us", "published_at": "2020-12-01T20:47:15+00:00", "published_display": "01 Dec 2020 20:47", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 72, "total_relevant": 13, "sentiment_summary": {"positive": 4, "negative": 0, "neutral": 9, "score": 53, "total": 13, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 90, "events": [{"event": "general", "label": "Market update", "weight": 6.05, "count": 11}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 4, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 570.0, "latest_week": "2026-06-19", "one_week_move": 4.2, "four_week_move": 23.9, "twelve_week_move": 9.6, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.188623, "market_dynamics_buy_signal": false, "relative_strength": 13.294283, "fair_value_gap": 10.7, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 22.8916, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+4.2% over one week, +23.9% over four weeks, trend active, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 65, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 6}, {"label": "MSN", "count": 1}, {"label": "Stock Titan", "count": 1}, {"label": "Investing.com", "count": 1}, {"label": "simplywall.st", "count": 1}, {"label": "ChartMill", "count": 1}, {"label": "The Motley Fool", "count": 1}, {"label": "StockInvest.us", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 13}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 11}, {"label": "Earnings", "count": 1}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "90/100 classification confidence."}, {"label": "Company focus", "value": "13", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+4.2% over one week, +23.9% over four weeks, trend active, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Beam Therapeutics stock soars 21% in three months: Here's why"}], "updated_at": "2026-06-23T01:41:41.370270+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}